The present invention relates to a toxin comprising a modified light chain of a botulinum toxin type E, wherein the modified light chain comprises amino acid sequence PFVNKQFN (SEQ ID NO: 120) at the N-terminus, and amino acid sequence xDxxxLL (SEQ ID NO: 111) at the C-terminus, wherein x is any amino acid.

 
Web www.patentalert.com

< p16 MEDIATED REGULATION OF NMDA RECEPTORS

< USE OF CHITOSANS TO INCREASE NAIL GROWTH RATE

> Translation Enhancer Elements Of Genes Encoding Human Tau Protein and Human Alpha-Synuclein Protein

> HUMAN SKELETAL MUSCLE-SPECIFIC UBIQUITIN-CONJUGATING ENZYME
~ 00618